Although 3-BrPA was proven to be an inhibitor of PDH [72,73,74], this cannot explain the antitumor effect of 3-BrPA because it would sustain the tumor metabolic profile rather than destroying it, as noted above. Here, PDP1 is linked to neoplasm.